@reeno I read that researchers are conducting clinical trials that use existing oral drugs, such as hydroxychloroquine and everolimus, to target and eliminate dormant breast cancer cells. These "sleeper cells" are resistant to traditional chemotherapy and can reactivate years later, leading to recurrence. Early trial results are promising, showing that the drugs can clear dormant cells and significantly lower recurrence rates in participants.